Mojca Stegnar

1.6k total citations
75 papers, 1.3k citations indexed

About

Mojca Stegnar is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Mojca Stegnar has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 20 papers in Internal Medicine and 17 papers in Surgery. Recurrent topics in Mojca Stegnar's work include Venous Thromboembolism Diagnosis and Management (20 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Blood properties and coagulation (11 papers). Mojca Stegnar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (20 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Blood properties and coagulation (11 papers). Mojca Stegnar collaborates with scholars based in Slovenia, Austria and Poland. Mojca Stegnar's co-authors include Polona Peternel, Mojca Božič Mijovski, D. Keber, Vita Dolžan, Katja Breskvar, D. Kikelj, Alenka Mavri, Aleš Blinc, Nina Vene and Janez Ilaš and has published in prestigious journals such as Journal of Medicinal Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and European Journal of Medicinal Chemistry.

In The Last Decade

Mojca Stegnar

72 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojca Stegnar Slovenia 20 321 284 234 226 209 75 1.3k
E. Seifried Germany 18 316 1.0× 367 1.3× 242 1.0× 251 1.1× 779 3.7× 44 1.9k
Vijay Upreti United States 20 131 0.4× 276 1.0× 166 0.7× 403 1.8× 328 1.6× 55 1.7k
Teddy Kosoglou United States 26 111 0.3× 757 2.7× 102 0.4× 194 0.9× 213 1.0× 65 2.2k
Marta Brambilla Italy 24 397 1.2× 362 1.3× 159 0.7× 424 1.9× 26 0.1× 78 1.8k
Zhaoqing Wang United States 17 227 0.7× 906 3.2× 327 1.4× 391 1.7× 167 0.8× 46 2.1k
O. Vesterqvist Sweden 20 91 0.3× 461 1.6× 83 0.4× 303 1.3× 68 0.3× 60 1.4k
Paola Filabozzi Italy 12 111 0.3× 850 3.0× 283 1.2× 65 0.3× 61 0.3× 17 1.5k
John W. Burch United States 11 175 0.5× 519 1.8× 176 0.8× 202 0.9× 35 0.2× 17 1.2k
Jean Combalbert France 12 120 0.4× 778 2.7× 169 0.7× 201 0.9× 579 2.8× 14 1.8k
Sven Nylander Sweden 26 415 1.3× 1.4k 5.1× 569 2.4× 431 1.9× 75 0.4× 52 2.6k

Countries citing papers authored by Mojca Stegnar

Since Specialization
Citations

This map shows the geographic impact of Mojca Stegnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Stegnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Stegnar more than expected).

Fields of papers citing papers by Mojca Stegnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Stegnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Stegnar. The network helps show where Mojca Stegnar may publish in the future.

Co-authorship network of co-authors of Mojca Stegnar

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Stegnar. A scholar is included among the top collaborators of Mojca Stegnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Stegnar. Mojca Stegnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blinc, Aleš, Matija Kozak, Mišo Šabović, et al.. (2017). Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease. International Angiology. 36(3). 216–227. 14 indexed citations
2.
Mijovski, Mojca Božič, Mojca Stegnar, Vladka Salapura, et al.. (2012). Nurr1 Haplotypes are Associated with Femoropopliteal Restenosis/Re-occlusion after Percutaneous Transluminal Angioplasty. European Journal of Vascular and Endovascular Surgery. 43(3). 337–338. 7 indexed citations
3.
Mijovski, Mojca Božič, et al.. (2007). Major and Potential Prothrombotic Genotypes in Patients with Venous Thrombosis and in Healthy Subjects from Slovenia. Pathophysiology of Haemostasis and Thrombosis. 36(2). 58–63. 19 indexed citations
4.
Stegnar, Mojca, Mojca Božič Mijovski, Marija Sollner Dolenc, Marko Anderluh, & D. Kikelj. (2007). Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro. Clinical Chemistry and Laboratory Medicine (CCLM). 45(11). 1542–8. 4 indexed citations
5.
Mijovski, Mojca Božič, et al.. (2007). Variation in Platelet Function Testing Has a Major Influence on Detection of Aspirin Resistance in Healthy Subjects. Pathophysiology of Haemostasis and Thrombosis. 36(2). 84–90. 8 indexed citations
6.
Mijovski, Mojca Božič, Aleksandra Antovič, Polona Peternel, et al.. (2006). Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia. Thrombosis Research. 120(1). 39–46. 21 indexed citations
7.
Locatelli, Igor, Iztok Grabnar, Polona Peternel, et al.. (2006). The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose. European Journal of Clinical Pharmacology. 62(4). 291–296. 37 indexed citations
8.
Locatelli, Igor, Iztok Grabnar, Polona Peternel, et al.. (2005). Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose. The Pharmacogenomics Journal. 5(3). 193–202. 103 indexed citations
9.
Anderluh, Marko, Petra Peharec Štefanić, D. Kikelj, et al.. (2004). Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study. European Journal of Medicinal Chemistry. 40(1). 25–49. 39 indexed citations
10.
Blinc, Aleš, Mojca Božič Mijovski, Rok Vengust, & Mojca Stegnar. (2004). Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro. Thrombosis Research. 114(3). 179–184. 30 indexed citations
11.
Peternel, Luka, et al.. (2004). Evaluation of two experimental venous thrombosis models in the rat. Thrombosis Research. 115(6). 527–534. 14 indexed citations
12.
Mašič, Lucíja Peterlin, et al.. (2003). Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-Arginine mimetics. Bioorganic & Medicinal Chemistry Letters. 13(5). 789–794. 16 indexed citations
13.
Stegnar, Mojca, Nina Vene, & Mojca Božič Mijovski. (2003). Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?. Pathophysiology of Haemostasis and Thrombosis. 33(5-6). 302–308. 20 indexed citations
14.
Mijovski, Mojca Božič, Aleš Blinc, & Mojca Stegnar. (2002). D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis. Thrombosis Research. 108(2-3). 107–114. 43 indexed citations
15.
Salobir, Barbara, Mišo Šabović, Polona Peternel, Mojca Stegnar, & Anton Grad. (2002). Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions. Acta Neurologica Scandinavica. 105(3). 189–195. 14 indexed citations
16.
Mavri, Alenka, Mojca Stegnar, & Mišo Šabović. (2001). Do baseline serum leptin levels predict weight regain after dieting in obese women?. Diabetes Obesity and Metabolism. 3(4). 293–296. 29 indexed citations
17.
Božič, Borut, Tanja Kveder, Mojca Stegnar, et al.. (1997). Influence of Degraded Phosphatidylserine on Binding of Antiphospholipid Antibodies. International Archives of Allergy and Immunology. 112(1). 19–26. 27 indexed citations
18.
19.
Stegnar, Mojca, et al.. (1993). Fibrinolytic response to venous occlusion in healthy subjects: Relationship to age, gender, body weight, blood lipids and insulin. Thrombosis Research. 69(1). 81–92. 43 indexed citations
20.
Stegnar, Mojca, Polona Peternel, D. Keber, & Nina Vene. (1991). Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. Thrombosis Research. 64(4). 445–453. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Seifried Breakdown of academic impact, for papers by Vijay Upreti Breakdown of academic impact, for papers by Teddy Kosoglou Breakdown of academic impact, for papers by Marta Brambilla Breakdown of academic impact, for papers by Zhaoqing Wang Breakdown of academic impact, for papers by O. Vesterqvist Breakdown of academic impact, for papers by Paola Filabozzi Breakdown of academic impact, for papers by John W. Burch Breakdown of academic impact, for papers by Jean Combalbert Breakdown of academic impact, for papers by Sven Nylander
Rankless by CCL
2026